X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (29) 29
humans (26) 26
oncology (22) 22
surgery (19) 19
female (17) 17
male (16) 16
middle aged (14) 14
sarcoma (14) 14
adult (13) 13
cancer (13) 13
tumors (13) 13
aged (12) 12
aged, 80 and over (11) 11
animals (11) 11
prognosis (11) 11
sarcoma - pathology (10) 10
mice (9) 9
metastasis (7) 7
radiotherapy (7) 7
risk factors (7) 7
adolescent (6) 6
patients (6) 6
prospective studies (6) 6
retroperitoneal neoplasms - pathology (6) 6
retroperitoneal neoplasms - surgery (6) 6
abridged index medicus (5) 5
aggressive fibromatosis (5) 5
care and treatment (5) 5
cell line, tumor (5) 5
chemotherapy (5) 5
expression (5) 5
follow-up studies (5) 5
medicine & public health (5) 5
research (5) 5
sarcoma - genetics (5) 5
soft-tissue sarcoma (5) 5
surgical oncology (5) 5
young adult (5) 5
analysis (4) 4
cell biology (4) 4
cell line (4) 4
cells (4) 4
dna-binding proteins - genetics (4) 4
gene expression (4) 4
genes (4) 4
genetic aspects (4) 4
immunohistochemistry (4) 4
liposarcoma (4) 4
medical research (4) 4
mutation (4) 4
prognostic-factors (4) 4
proteins (4) 4
sarcoma - surgery (4) 4
treatment outcome (4) 4
angiosarcoma (3) 3
cell cycle proteins - genetics (3) 3
cell cycle proteins - metabolism (3) 3
cell differentiation (3) 3
development and progression (3) 3
dna-binding proteins - deficiency (3) 3
dna-binding proteins - metabolism (3) 3
genotype & phenotype (3) 3
health aspects (3) 3
incidence (3) 3
local recurrence (3) 3
management (3) 3
medicine (3) 3
medicine, research & experimental (3) 3
mesenchyme (3) 3
microrna (3) 3
neoplasm recurrence, local - pathology (3) 3
neoplasm staging (3) 3
protein-serine-threonine kinases - metabolism (3) 3
radiation therapy (3) 3
radiation-therapy (3) 3
research article (3) 3
resection (3) 3
retroperitoneal sarcoma (3) 3
series (3) 3
studies (3) 3
survival (3) 3
therapy (3) 3
transfection (3) 3
abdomen (2) 2
adenocarcinoma - surgery (2) 2
animal models (2) 2
article (2) 2
ataxia telangiectasia mutated proteins (2) 2
beta-catenin (2) 2
biology and life sciences (2) 2
biomarker (2) 2
biomarkers, tumor - genetics (2) 2
biopsy (2) 2
bone (2) 2
breast (2) 2
breast-cancer metastasis (2) 2
cancer surgery (2) 2
cancer therapies (2) 2
cancers and neoplasms (2) 2
carcinoma (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Investigation, ISSN 0021-9738, 10/2014, Volume 124, Issue 10, pp. 4305 - 4319
Journal Article
Cancer, ISSN 0008-543X, 03/2019, Volume 125, Issue 5, pp. 670 - 672
Dermatofibrosarcoma is a dermal sarcoma that is predominately indolent, and local recurrence is the main pattern of failure. In this editorial, the need to... 
ONCOLOGY | IMATINIB | Sarcoma | Surveillance | Skin | Dermatofibrosarcoma protuberans | Risk analysis | Patients | Risk factors
Journal Article
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 01/2018, Volume 117, Issue 1, pp. 69 - 78
Retroperitoneal sarcoma (RPS) patients can have variable of outcomes after surgery. The chance to recur locally or at distant sites varies according to tumor... 
retroperitoneal sarcoma | sarcoma | nomogram | prognosis | Medicine, Experimental | Medical research
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2014, Volume 9, Issue 4, p. e94817
Journal Article
Journal Article
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 12/2017, Volume 116, Issue 8, pp. 1056 - 1061
Background Breast angiosarcoma (AS) accounts for less than 1% of all breast cancers. The goal of this study was to determine patient outcomes in... 
angiosarcoma | breast | radiation‐associated sarcoma | radiation-associated sarcoma | SURGERY | ONCOLOGY | Medicine, Experimental | Medical research | Angiosarcoma | Patient outcomes
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 2016, Volume 14, Issue 1, p. 67
Background: Leiomyosarcoma (LMS) is a common type of soft tissue sarcoma that responds poorly to standard chemotherapy. Thus the goal of this study was to... 
Drug discovery | PI3K | Sarcoma | Doxorubicin | MTOR | Leiomyosarcoma | MEDICINE, RESEARCH & EXPERIMENTAL | ADVANCED SOLID TUMORS | AKT ACTIVATION | MTOR PATHWAY | I PI3K INHIBITOR | PATHWAY INHIBITION | BREAST-CANCER | DOSE-ESCALATION | mTOR | PI3-KINASE INHIBITOR | DRUG-COMBINATION | SOFT-TISSUE SARCOMA | Doxorubicin - therapeutic use | TOR Serine-Threonine Kinases - metabolism | Apoptosis - drug effects | Humans | Phosphatidylinositol 3-Kinases - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Quinolines - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | TOR Serine-Threonine Kinases - antagonists & inhibitors | Aminopyridines - therapeutic use | Female | Imidazoles - therapeutic use | Drug Evaluation, Preclinical | Proto-Oncogene Proteins c-akt - metabolism | Morpholines - therapeutic use | Reproducibility of Results | Leiomyosarcoma - pathology | Morpholines - pharmacology | Imidazoles - pharmacology | Drug Synergism | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Aminopyridines - pharmacology | Cell Line, Tumor | Leiomyosarcoma - drug therapy | Mice, Inbred NOD | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Quinolines - therapeutic use | Doxorubicin - pharmacology | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Complications and side effects | Chemotherapy | Anthracyclines | Care and treatment | Development and progression | Research | Health aspects | Cancer
Journal Article